Isoplexis Corporation Receivables Turnover Ratio (ISO), from the fourth quarter 2022 to the fourth quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Isoplexis Corporation  (NASDAQ: ISO)
 

Isoplexis Accounts Receivables Turnover Ratio from the fourth quarter 2022 to the fourth quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Isoplexis Corporation's ability to collect accounts receivable sequentially worsen to 4.01, indicating more challenging environment then in the third quarter 2022, but still, it is a far cry from any concerns. Isoplexis's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 91 days, from 78 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 593 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 3607 to 4174.

What is Receivable Turnover Ratio?
What is Isoplexis Corporation Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ISO Receivables Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Receivable Change 9.8 % 30.8 % 6868 % - -
Y / Y Revenue Change -40.26 % 6.32 % -9.33 % 51.02 % -22.03 %
Receivable Turnover Ratio (TTM) 4.01 4.66 4.93 6.53 9.03
ISO's Total Ranking # 4174 # 3607 # 3852 # 0 # 0
Accounts Receivable average collection period days 91 78 74 56 40
Seq. Receivable Change -1.47 % 31.14 % -11.51 % -3.98 % 17.38 %
Seq. Revenue Change -25.5 % 14.27 % -20.37 % -11.87 % 32.58 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 27
Healthcare Sector # 594
Overall Market # 4174

Receivable Turnover Ratio Statistics
High Average Low
0.13 0.12 0.12
(Mar 31 2022)   (Sep 30 2022)





ISO Company Profile • Back to ISO Efficiency Comparisons • Compare ISO Receivables Turnover Ratio to its Competitors

Financial Statements
Isoplexis's Accounts Receivable $ 5 Millions Visit ISO's Balance sheet
Isoplexis's Sales TTM $ 17 Millions Visit ISO's Income Statement
Sources of ISO's Revenues Visit ISO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ISO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ISO's Growth Rates ISO's Roa ISO's Inventory Turnover Ratio ISO's Dividend Comparisons
ISO's Profitability Ratios ISO's Roi ISO's Asset Turnover Ratio ISO's Dividend Growth
ISO's Valuation Ratios ISO's Roe ISO's Financial Strength Ratios ISO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Receivable at quarter ending Dec 31 2022
G Medical Innovations Holdings Ltd   10.02 $ 4.420  Millions$ 0.441  Millions
Cerus Corporation  9.98 $ 287.164  Millions$ 28.765  Millions
Surmodics Inc   9.95 $ 101.881  Millions$ 10.235  Millions
Sunlink Health Systems Inc   9.95 $ 46.018  Millions$ 4.624  Millions
Intercept Pharmaceuticals inc   9.95 $ 315.146  Millions$ 31.673  Millions
Cartesian Therapeutics Inc   9.92 $ 110.777  Millions$ 11.167  Millions
Atrion Corporation  9.91 $ 183.506  Millions$ 18.523  Millions
Immucell Corporation  9.87 $ 18.568  Millions$ 1.882  Millions
Procyon Corporation  9.87 $ 4.681  Millions$ 0.475  Millions
Barinthus Biotherapeutics Plc  9.74 $ 44.703  Millions$ 4.590  Millions
Adc Therapeutics Sa  9.73 $ 350.018  Millions$ 35.959  Millions
United Therapeutics Corporation  9.73 $ 1,936.300  Millions$ 199.000  Millions
Rockwell Medical inc   9.72 $ 70.049  Millions$ 7.209  Millions
Milestone Scientific Inc   9.59 $ 8.806  Millions$ 0.919  Millions
Viemed Healthcare Inc   9.53 $ 138.832  Millions$ 14.562  Millions
Myomo Inc   9.51 $ 15.555  Millions$ 1.635  Millions
Sanara Medtech Inc   9.42 $ 45.843  Millions$ 4.868  Millions
Utah Medical Products Inc  9.41 $ 52.281  Millions$ 5.557  Millions
Vbi Vaccines Inc  9.35 $ 1.082  Millions$ 0.116  Millions
Heska Corporation  9.33 $ 257.307  Millions$ 27.584  Millions
Alpha Pro Tech Ltd   9.28 $ 61.981  Millions$ 6.678  Millions
Q Biomed inc   9.09 $ 0.284  Millions$ 0.031  Millions
Sunshine Biopharma Inc   9.09 $ 4.346  Millions$ 0.478  Millions
Ardelyx inc   9.09 $ 52.158  Millions$ 5.740  Millions
Anaptysbio Inc   9.04 $ 10.287  Millions$ 1.138  Millions
Novavax inc   9.00 $ 1,981.872  Millions$ 220.136  Millions
Protalix Biotherapeutics inc   9.00 $ 47.638  Millions$ 5.292  Millions
Nexgel Inc   8.91 $ 2.048  Millions$ 0.230  Millions
Lensar Inc   8.87 $ 35.358  Millions$ 3.986  Millions
Harmony Biosciences Holdings inc   8.86 $ 437.855  Millions$ 49.440  Millions

Date modified: 2026-10-07T00:41:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.